Home | Archives | Products | About | Contact | FAQ |
New User? Sign Up | Sign In
Sec Filings Insider Trading - Suzdak Peter David
Select Time period:       google icon google     yahoo icon yahoo!
Send this page to:   blogger icon Blog    digg icon Digg    reddit icon Reddit    facebook icon Facebook    stumble icon Stumble    delicious icon del.icio.us

Enter Stock Ticker Symbol or Cik: SEC Cik Lookup Cik Lookup...

Search By Company or Insider Name: Powered by Google button
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch ==>> What is insider trading>>
Insider Trading Transactions for Suzdak Peter David
Historical filings delayed by 6 months. New user? Sign Up for real time data. Existing user? Sign In
Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
Date
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2017-08-16
Option Award
2017-08-16
4:05 pm
N/A
N/A
Rexahn Pharmaceuticals Inc RNN Suzdak Peter David
Chief Executive Officer
Director
10,000 $1.987 16,000
(Direct)
View
2017-01-20
Option Award
2017-01-24
5:50 pm
N/A
2027-01-20
Rexahn Pharmaceuticals Inc RNN Suzdak Peter David
Chief Executive Officer
Director
1,175,000 $0.184 1,175,000
(Direct)
View
2017-01-20
Option Award
2017-01-24
5:50 pm
N/A
N/A
Rexahn Pharmaceuticals Inc RNN Suzdak Peter David
Chief Executive Officer
Director
250,000 $0 1,175,000
(Direct)
View
2016-03-18
Option Award
2016-03-21
9:20 pm
N/A
N/A
Rexahn Pharmaceuticals Inc RNN Suzdak Peter David
Chief Executive Officer
Director
60,000 $0.3231 60,000
(Direct)
View
2016-01-28
Option Award
2016-02-01
4:32 pm
2017-01-28
2026-01-28
Rexahn Pharmaceuticals Inc RNN Suzdak Peter David
Chief Executive Officer
Director
411,689 $0.35 1,000,000
(Direct)
View
2016-01-28
Option Award
2016-02-01
4:32 pm
N/A
2026-01-28
Rexahn Pharmaceuticals Inc RNN Suzdak Peter David
Chief Executive Officer
Director
1,000,000 $0.35 1,000,000
(Direct)
View